A recent modeling study has revealed that only 6.9% of carbapenem-resistant Gram-negative (CRGN) bacterial infections received appropriate treatment in 2019…
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.